To compare anti-Ro52 autoantibody molecular characteristics, including immunoglobulin variable region usage and somatic hypermutation, in patients with isolated and combined serological profiles, we subjected 15 SS patients’ anti-Ro52 IgG to mass spectrometric (MS) analyses. The gene discussed is TRIM21; the disease is synovial sarcoma.